58.73USD-2.43%Mkt Cap: 4.69B $P/E: 54.381d ago
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for …
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/E
Pricier
P/B
Avg
1M Perf
Lower
$186.32BUSDP/E 27.6
$134.82BUSDP/E 36.8
$43.51BUSDP/E 42.0
$41.53BUSDP/E 38.7
$38.88BUSD
$37.53BUSDP/E 26.7
$36.82BUSDP/E 47.7
$32.25BUSDP/E 24.0
$26.60BUSDP/E 31.9
$25.82BUSDP/E 30.0
$23.46BUSDP/E 23.4
$22.96BUSDP/E 24.8
$19.89BUSD
$15.12BUSDP/E 33.3
$12.91BUSDP/E 26.9
$12.41BUSDP/E 53.5
$10.92BUSD
$8.81BUSDP/E 20.6
$6.41BUSD
$5.52BUSDP/E 222.2
$5.06BUSDP/E 43.3
$4.85BUSD
$3.65BUSDP/E 25.7
$3.43BUSD
$2.93BUSD
$2.04BUSD
$1.90BUSD
$1.48BUSDP/E 37.4
$1.48BUSDP/E 22.4
$1.47BUSD
$1.40BUSD
$1.13BUSD
$1.01BUSDP/E 21.1
$723.37MUSD
$615.20MUSDP/E 40.1
$582.78MUSD
$539.30MUSD
$297.38MUSDP/E 3.0
$282.06MUSD
$233.52MUSD
$190.51MUSD
$147.80MUSD
$112.34MUSD
$94.30MUSDP/E 18.2
$77.88MUSD
$58.94MUSD
$44.26MUSD
$27.97MUSD
$27.15MUSD
$22.69MUSD
$17.60MUSD
$12.55MUSD
$10.07MUSDP/E 63.2
$9.85MUSD
$9.02MUSD
$8.78MUSD
$6.77MUSD
$6.29MUSD
$5.98MUSD
$5.10MUSD
$4.66MUSD
$3.81MUSD
$3.86MUSDP/E 2.8
$2.93MUSD
$2.79MUSD
$2.43MUSD
$1.29MUSD
$314.2KUSDP/E Infinity
$14.0KUSD
Indicators:|
Key Statistics
Company
Market Cap4.69B $
Enterprise Value4.29B $
Revenue (TTM)541.74M $
Gross Profit362.53M $
Net Income (TTM)66.35M $
Revenue/Share6.861 USD
Last Price58.73 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees755
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS92337F1075
Valuation
P/E (Trailing)54.38
P/E (Forward)30.89
PEG—
EV/EBITDA41.13
EV/Revenue7.91
P/S8.65
P/B3.56
EPS (TTM)1.08
EPS (Forward)1.90
52W Range
22.6194% of range60.91
52W High60.91 USD
52W Low22.61 USD
Profitability
Gross Margin70.10%
Oper. Margin16.28%
EBITDA Margin19.24%
Profit Margin12.83%
ROE5.07%
ROA4.72%
Growth
Revenue Growth21.50%
Earnings Growth288.90%
Cash Flow & Leverage
Operating CF136.31M $
CapEx (TTM)9.68M $
FCF Margin19.29%
FCF Yield2.23%
Net Debt-399.73M $
Net Debt/EBITDA-3.84
Balance Sheet
Debt/Equity0.03
Current Ratio9.30
Quick Ratio8.72
Book Value/Sh16.50 USD
Cash/Share5.503 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)49.10 USD
Upside (mean)-16.4%
Target Range37.00 USD – 57.00 USD
$37.00-16.4% to mean$57.00
# Analysts10
Ownership
Shares Out.79.79M
Float79.28M
Insiders0.55%
Institutions113.02%
Short Interest
Short Ratio6.9d
Short % Float12.59%
Short % Out.10.64%
Shares Short8.49M
Short (prev mo.)8.59M
Technical
SMA 5043.66 (+34.5%)
SMA 20039.20 (+49.8%)
Beta1.98
S&P 52W Chg20.05%
Avg Vol (30d)1.20M
Avg Vol (10d)1.80M
Technical Indicators
RSI (14)73.2
MACD4.2359
MACD Signal3.6411
MACD Hist.+0.5949
BB Upper61.23 USD
BB Middle52.05 USD
BB Lower42.88 USD
BB Width35.26%
ATR (14)2.509 USD
Vol Ratio (20d)0.99x